Mar 12, 2026
21:20
For every 20 shares held, investors received 21. The price per share adjusted from $3070.00 to $2923.81.
The split itself did not change the total investment value.
HLB Therapeutics Co., Ltd. (KRX:115450) operates in the Medical distributors industry.
HLB Therapeutics Co., Ltd. company overviewHLB Therapeutics Co., Ltd.'s most recent stock split was on March 12, 2026. It was a 21-for-20 forward split, so shareholders received 21 shares for every 20 they held.
HLB Therapeutics Co., Ltd. (KRX:115450) has split its stock 6 times: a 751-for-592 split on December 18, 2013, a 207-for-200 split on December 28, 2022, a 2-for-1 split on March 15, 2023, a 207-for-200 split on December 27, 2023, a 21-for-20 split on January 14, 2025, and a 21-for-20 split on March 12, 2026.
HLB Therapeutics Co., Ltd. has split its stock 6 times. This history records 6 forward splits between December 18, 2013 and March 12, 2026.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In HLB Therapeutics Co., Ltd.'s 21-for-20 split on March 12, 2026, every 20 shares became 21 shares.
HLB Therapeutics Co., Ltd. has not announced a new split in our records. Its most recent split was on March 12, 2026, less than a year ago. Companies announce splits in advance, and any new KRX:115450 split will appear on this page.
Already premium?